MICHAEL LEWIS to Molecular Targeted Therapy
This is a "connection" page, showing publications MICHAEL LEWIS has written about Molecular Targeted Therapy.
Connection Strength
0.071
-
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.
Score: 0.038
-
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer. Nat Commun. 2018 09 19; 9(1):3815.
Score: 0.033